Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Oncology | Pulmonary/Respiratory Diseases

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Sclerosol Intrapleural Aerosol

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Bryan Corporation
Approval Status: Approved January 1998
Treatment Area: malignant pleural effusions

General Information

Sclerosol Intrapleural Aerosol has been approved for the prevention of recurrence of malignant pleural effusions in symptomatic patients. Symptoms include chest pain, dyspnea, and coughing. It is to be administered by aerosol during thracoscopy or open thoracotomy.